T. Rowe Price Associates’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $293M | Buy |
|
|||||
|
2025
Q3 | $81.4M | Buy |
|
|||||
|
2025
Q2 | $41.5M | Sell |
|
|||||
|
2025
Q1 | $40.3M | Buy |
|
|||||
|
2024
Q4 | $27.2M | Buy |
|
|||||
|
2024
Q3 | $20.6M | Sell |
|
|||||
|
2024
Q2 | $20.9M | Buy |
|
|||||
|
2024
Q1 | $24.9M | Buy |
|
|||||
|
2023
Q4 | $26.6M | Buy |
|
|||||
|
2023
Q3 | $1.64M | Buy |
|
|||||
|
2023
Q2 | $1.03M | Buy |
|
|||||
|
2023
Q1 | $916K | Sell |
|
|||||
|
2022
Q4 | $507K | Sell |
|
|||||
|
2022
Q3 | $828K | Sell |
|
|||||
|
2022
Q2 | $819K | Buy |
|
|||||
|
2022
Q1 | $672K | Buy |
|
|||||
|
2021
Q4 | $700K | Sell |
|
|||||
|
2021
Q3 | $2.08M | Sell |
|
|||||
|
2021
Q2 | $33.1M | Sell |
|
|||||
|
2021
Q1 | $37.3M | Buy |
|
|||||
|
2020
Q4 | $2.15M | Buy |
|
|||||
|
2020
Q3 | $1.02M | Buy |
|
|||||
|
2020
Q2 | $586K | Buy |
|
|||||
|
2020
Q1 | $514K | Buy |
|